Bonifacio R, Alfonsi L, Santarpia L, Orban A, Celona A, Negro G, Pasanisi F, Contaldo F
Internal Medicine and Clinical Nutrition, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy.
Intern Emerg Med. 2007 Oct;2(3):188-95. doi: 10.1007/s11739-007-0056-4. Epub 2007 Oct 3.
Forty-one (20 m, 21 f) non-oncological home parenteral nutrition (HPN) patients (52.0+/-16.6 years, BMI 20.2+/-4.0 kg/m(2)), enrolled from 1995 to 2005, underwent a clinical and biochemical follow-up at 3 months, 1 and 3 years.
At admittance the Karnofsky Index ranged between 40 and 50 in 13 (31.7%) and 60 and 80 in 28 (68.3%) patients; the most frequent underlying disease was mesenteric infarction (11 patients, 27%). All had a central venous access. Mean catheterization days were 864+/-992, while mean HPN days were 630+/-668. At the 3-month follow-up, all patients were on HPN, at 1 year 24 (58.5%) and at 3 years 11 (27%). At 3 months, 1 and 3 years there was a significant increase in BMI (p=0.001), body weight (p=0.001) and Karnofsky Index (p=0.001), as well as an improvement of several biochemical parameters. Survival rate of HPN patients was 90.2% at 1 year, 87.8% at 3 years and 82.9% at 5 years. As to HPN-related complications, there was a central venous catheter (CVC) obstruction in 8 patients (19.5%) and 47 CVC infections in 24 (58.5%) patients. The infection rate was 1.32/(00) days of catheterization (1.8/(00) from 1995 to 1998 and 1.0/(00) from 1999 to 2005). Hospitalisation was necessary in over 50% of patients, and death occurred in 8, always as a consequence of the primary disease.
The experience of the nutritional team and careful patient and caregiver training reduce CVC infection rate and the overall risk of complications possibly due to HPN.
1995年至2005年纳入的41例(20例男性,21例女性)非肿瘤性家庭肠外营养(HPN)患者(年龄52.0±16.6岁,体重指数20.2±4.0kg/m²),在3个月、1年和3年时接受了临床和生化随访。
入院时,13例(31.7%)患者的卡诺夫斯基指数在40至50之间,28例(68.3%)患者在60至80之间;最常见的基础疾病是肠系膜梗死(11例患者,27%)。所有患者均有中心静脉通路。平均置管天数为864±992天,而平均HPN天数为630±668天。在3个月的随访中,所有患者均接受HPN治疗,1年时24例(58.5%),3年时11例(27%)。在3个月、1年和3年时,体重指数(p=0.001)、体重(p=图001)和卡诺夫斯基指数(p=0.001)均显著增加,同时多项生化指标也有所改善。HPN患者1年生存率为90.2%,3年生存率为87.8%,5年生存率为82.9%。关于HPN相关并发症,8例患者(19.5%)发生中心静脉导管(CVC)阻塞,24例患者(58.5%)发生47次CVC感染。感染率为1.32/(每100)置管日(1995年至1998年为1.8/(每100),1999年至2005年为1.0/(每100))。超过50%的患者需要住院治疗,8例患者死亡,均因原发性疾病所致。
营养团队的经验以及对患者和护理人员的精心培训可降低CVC感染率以及可能由HPN引起的总体并发症风险。